Top 10 Analyst Upgrades and Downgrades: Chevron, Facebook, Idenix, Newmont and More
Investors and traders are often on the hunt for fresh research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street firms and from boutique firms to find great ideas in value stocks, growth stocks and dividend stocks. Some are stocks to buy, while some ideas are even stocks to sell. These are 10 of the top analyst upgrades, downgrades and initiations seen from select Wall Street research calls this Friday.
Allergan Inc. (NYSE: AGN) was downgraded to Neutral from Buy at Goldman Sachs.
Cardinal Health Inc. (NYSE: CAH) upgraded to Outperform from Market Perform at William Blair.
Chevron Corp. (NYSE: CVX) was started as Outperform at Wells Fargo (late Thursday call).
Exxon Mobil Corp. (NYSE: XOM) was started as Market Perform at Wells Fargo (late Thursday call).
Facebook Inc. (NASDAQ: FB) upgraded to Buy from Neutral at UBS
Forest Laboratories Inc. (NYSE: FRX) was upgraded to Buy from Neutral at Goldman Sachs.
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) has run into an FDA delay of its hepatitis C drug trial and shares are down by more than a third. Analysts have downgraded in mass: to Underperform at Baird, to Hold at Deutsche Bank, to Underperform at JMP Securities and to Neutral at J.P. Morgan.
Kimberly-Clark Corp. (NYSE: KMB) was upgraded to Market Perform from Underperform at BMO Capital Markets. We also just named this as one of four key stocks that investors will flock back into after the market flush ends.
Newmont Mining Corp. (NYSE: NEM) was downgraded to Neutral from Buy at UBS, after being downgraded by Cowen & Co. yesterday.
Read also: UBS Updated Its Key Call List of Stocks
The Wendy’s Co. (NASDAQ: WEN) was started as Market Perform at Wells Fargo.